113 related articles for article (PubMed ID: 1358055)
21. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
22. Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury.
Tang YP; Noda Y; Nabeshima T
Eur J Neurosci; 1997 Aug; 9(8):1720-7. PubMed ID: 9283826
[TBL] [Abstract][Full Text] [Related]
23. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the NMDA competitive antagonist CPP and the dopaminergic system in one-trial inhibitory avoidance in C57BL/6 mice.
Mele A; Castellano C; Cestari V; Oliverio A
Neurobiol Learn Mem; 1995 Mar; 63(2):143-8. PubMed ID: 7663887
[TBL] [Abstract][Full Text] [Related]
25. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
Zetterström T; Sharp T; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
[TBL] [Abstract][Full Text] [Related]
26. Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems.
Lalumiere RT; Nguyen LT; McGaugh JL
Eur J Neurosci; 2004 Nov; 20(10):2804-10. PubMed ID: 15548223
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.
Lublin H
Clin Neuropharmacol; 1995 Dec; 18(6):533-51. PubMed ID: 8681313
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective dopamine D1 and D2 receptor agonists on the rate of GABA synthesis in mouse brain.
Steulet AF; Bernasconi R; Leonhardt T; Martin P; Grünenwald C; Bischoff S; Heinrich M; Bandelier V; Maître L
Eur J Pharmacol; 1990 Nov; 191(1):19-27. PubMed ID: 1982657
[TBL] [Abstract][Full Text] [Related]
29. Strain-dependent effects of cocaine on memory storage improvement induced by post-training physostigmine.
Castellano C; Zocchi A; Cabib S; Puglisi-Allegra S
Psychopharmacology (Berl); 1996 Feb; 123(4):340-5. PubMed ID: 8867873
[TBL] [Abstract][Full Text] [Related]
30. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
Ichihara K; Nabeshima T; Kameyama T
Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736
[TBL] [Abstract][Full Text] [Related]
31. Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: an in vivo study in mice.
Imperato A; Obinu MC; Mascia MS; Casu MA; Zocchi A; Cabib S; Puglisi-Allegra S
Neuroscience; 1996 Feb; 70(3):653-60. PubMed ID: 9045078
[TBL] [Abstract][Full Text] [Related]
32. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.
Bernaerts P; Tirelli E
Behav Brain Res; 2003 Jun; 142(1-2):41-52. PubMed ID: 12798264
[TBL] [Abstract][Full Text] [Related]
33. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
[TBL] [Abstract][Full Text] [Related]
34. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
Bergman J; Madras BK; Spealman RD
J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
[TBL] [Abstract][Full Text] [Related]
35. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
36. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
37. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
Popoli P; Caporali MG; Scotti de Carolis A
Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
[TBL] [Abstract][Full Text] [Related]
38. MK-801 potentiates morphine-induced impairment of memory consolidation in mice: involvement of dopaminergic mechanisms.
Cestari V; Castellano C
Psychopharmacology (Berl); 1997 Sep; 133(1):1-6. PubMed ID: 9335074
[TBL] [Abstract][Full Text] [Related]
39. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
Winkler JD; Weiss B
J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
[TBL] [Abstract][Full Text] [Related]
40. Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.
Rosenzweig-Lipson S; Hesterberg P; Bergman J
Psychopharmacology (Berl); 1994 Sep; 116(1):9-18. PubMed ID: 7862937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
